Structured evidence table for Polypodium Leucotomos Skin Photoaging Randomized Trial, generated from 2 reusable source documents in the Migaku knowledge base.
| topic | claim | evidence level | citation | source |
|---|---|---|---|---|
| Polypodium Leucotomos Skin Photoaging Randomized Trial | Photoaging may not only affect quality of life, but also create substantial financial burden for patients, making its prevention and the practice of evidence-based treatments essential. | 3 | Tsai Jerry (2026) | Photoaging: Update on Pathogenesis, Prevention, and Treatment |
| Polypodium Leucotomos Skin Photoaging Randomized Trial | UVB, which primarily affects the epidermis and superficial dermis, is classically associated with the development of skin cancer through creation of cyclobutene pyrimidine dimers, pyrimidine-pyrimidone (6-4) photoproducts, and reactive oxygen species (ROS), as well as suppression of immune surveillance against tumors. | 3 | Tsai Jerry (2026) | Photoaging: Update on Pathogenesis, Prevention, and Treatment |
| Polypodium Leucotomos Skin Photoaging Randomized Trial | ECM degradation from chronic sun exposure also results in increased skin fragility and susceptibility of cutaneous vasculature to minor trauma, clinically manifesting as purpuric lesions known as solar purpura. | 3 | Tsai Jerry (2026) | Photoaging: Update on Pathogenesis, Prevention, and Treatment |
| Polypodium Leucotomos Skin Photoaging Randomized Trial | 1 2 Skin aging occurs through the passage of time (intrinsic aging) accompanied by environmental damage (extrinsic aging). | 3 | Tsai Jerry (2026) | Photoaging: Update on Pathogenesis, Prevention, and Treatment |
| Polypodium Leucotomos Skin Photoaging Randomized Trial | 1 2 3 4 5 6 7 8 9 10 11 12 13 Melasma is a common, multifactorial acquired skin disorder characterized by symmetric brown patches most often found on sun‐exposed areas of the face []. | 3 | Villani Alessia (2026) | A 50+ Sunscreen Containing Polypodium Leucotomos Extract, Ellagic Acid, and Niacinamide in Facial Melasma and Photoaging‐Related Hyperpigmentation: A Pilot Observational Study Using Line‐Field Confocal Optical Coherence Tomography |
| Polypodium Leucotomos Skin Photoaging Randomized Trial | This process leads to increased melanin production and persistent hyperpigmentation. | 3 | Villani Alessia (2026) | A 50+ Sunscreen Containing Polypodium Leucotomos Extract, Ellagic Acid, and Niacinamide in Facial Melasma and Photoaging‐Related Hyperpigmentation: A Pilot Observational Study Using Line‐Field Confocal Optical Coherence Tomography |
| Polypodium Leucotomos Skin Photoaging Randomized Trial | p p 2 Hyper‐reflective cells observed with LC‐OCT correspond to hyperpigmented basal keratinocytes, which can be reduced through treatment. | 3 | Villani Alessia (2026) | A 50+ Sunscreen Containing Polypodium Leucotomos Extract, Ellagic Acid, and Niacinamide in Facial Melasma and Photoaging‐Related Hyperpigmentation: A Pilot Observational Study Using Line‐Field Confocal Optical Coherence Tomography |
| Polypodium Leucotomos Skin Photoaging Randomized Trial | Among the factors that contribute to Melasma can be distinguished external factors, such as ultraviolet (UV) radiation exposure, and hormonal factors (including sex hormones, pregnancy, and oral contraceptives), as well as genetic predisposition and skin inflammation []. | 3 | Villani Alessia (2026) | A 50+ Sunscreen Containing Polypodium Leucotomos Extract, Ellagic Acid, and Niacinamide in Facial Melasma and Photoaging‐Related Hyperpigmentation: A Pilot Observational Study Using Line‐Field Confocal Optical Coherence Tomography |
Source documents